Drugs / Amoxicillin/Clavulanate
last change Feb 2007 re-read 2 minutes ago

Amoxicillin/Clavulanate

Developed for
sinusitis
Investigated by
Pfizer

Trials 1 · a red edge is where a trial was stopped

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00367120 Jun 2006 → Feb 2007 sinusitis Pfizer Completed No outcome recorded

Press releases naming this drug 1 release

DateIssuerRelease
2004-03-12 Teva Branded Pharmaceutical Products R&D, Inc. Teva Announces Approval Of Amoxicillin/Clavulanate Potassium For Oral Suspension tevapharm.com

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Amoxicillin/Clavulanate ClinicalTrials.gov intervention name — accepted as the source's own label NCT00367120
Known as Amoxicillin/Clavulanate Potassium “Azithromycin Extended Release (ZMAX) Versus Amoxicillin/Clavulanate Potassium In Subjects With Acute Bacterial Sinusitis” NCT00367120
Known as Augmentin “either Zmax (Azithromycin Extended Release) or Augmentin (Amoxicillin/Clavulanate)” NCT00367120